期刊文献+

pVHL/HIF通路与PI3K/PKB/FOXO通路在肾透明细胞癌发生、发展中的作用

The roles of pVHL/HIF pathway and PI3K/PKB/FOXO pathway in the tumorigenesis and development of the clear cell renal carcinoma(CCRCC)
下载PDF
导出
摘要 肿瘤抑制基因vonHipple-Lindau(简称VHL基因)的突变失活导致肿瘤细胞中缺氧诱导因子的累积,进而调节其下游靶基因的转录和表达,促进肿瘤内新生血管形成及细胞增殖,从而促进肾透明细胞癌的发生、发展。磷酸肌醇-3激酶/蛋白激酶B通路异常活化,在肾细胞肿瘤的发生、发展、转移中发挥重要作用。上述两通路存在着错综复杂的联系。本文通过分析两通路在肾肿瘤发生,发展中的作用,为探寻肾癌治疗的新靶点提供理论依据。 The mutation of yon Hippie -Lindau tumor suppressor gene results in the inactivation of pVHL, and abnormal accumulation of hypoxia inducible factor - α( HIF - α) , HIF - αregulates the transcription and expression of downstream genes, and promotes tumorigenesis and development of the clear cell renal cell carcinoma ( CCRCC ) through stimulating angiogenesis and cell proliferation. The abnormal activation of phosphatidyinositol 3 - kinase/protein kinase B (PI3K/PKB) pathway also plays important roles in tumorigenesis , development and metastasis of the renal cell carcinoma. There are complicated relationships between the two pathways above . This review tries to elucidate the roles of the two pathways in tumorigenesis and development of renal neoplasia , and find out new target of renal tumor therapy in the future for the clinic.
作者 何春锋 刘永
出处 《现代肿瘤医学》 CAS 2009年第11期2231-2234,共4页 Journal of Modern Oncology
关键词 肾肿瘤 VHL基因 缺氧诱导因子 磷酸肌醇-3激酶/蛋白激酶B FOXO转录因子 信号通路 renal neoplasia VHL gene hypoxia inducible factor phosphatidyinositol 3 - kinase/protein kinase B FOXO transcription factor signal pathway
  • 相关文献

参考文献29

  • 1Lonser RR,Glenn GM,Walther M,et al. yon Hippel -Lindau disease [ J ]. Lancet,2003,361 (9374) :2059 - 2067.
  • 2杨光华.病理学[M].北京:人民卫生出版社,2002.389.
  • 3Latif F, Tory K, Gnarra J, et al. Identification of the yon Hippel - Lindau disease tumor suppressor gene [ J ]. Science, 1993,260 (5112) :1317 - 1320.
  • 4Stebbins CE, Kaelin WG Jr, Pavletich NP. Structure of the VHL - ElonginC - ElonginB complex: implications for VHL tumor suppressor function [ J ]. Science, 1999,284 (5413) :455 - 461.
  • 5Maxwell PH, Pugh CW, Ratcliffe PJ. Insights into the role of the yon Hippel - Lindau gene product, A key player in hypoxic regulation[J]. Exp Nephrol,2001,9(4) :235 -240.
  • 6Wang GL, Semenza GL. Purification and characterization of hypoxia - inducible factor 1 [J]. J Biol Chem,1995,270(3) :1230 - 1237.
  • 7Maynard MA, Ohh M. Von Hippel - Lindau tumor suppressor protein and hypoxia - inducible factor in kidney cancer [ J ]. Am J Nephrol,2004,24( 1 ) :1 - 13.
  • 8Maxwell P. HIF - 1 : an oxygen response system with special relevance to the kidney [ J ]. J Am Soc Neprol,2003 ,14 :2712 -2722.
  • 9Ke Q, Costa M. Hypoxia - inducible factor - 1 ( HIF - 1 ) [ J ]. Mol Pharmaco1,2006,70 (5) : 1469 - 1480.
  • 10Raval RR,Lau KW,Tran MG,et al. Contrasting properties of hypoxia - inducible factor 1 ( HIF - 1 ) and HIF - 2 in von Hippel - Lindau - associated renal cell carcinoma [ J ]. Mol Cell Biol, 2005,25(13) :5675 -5686.

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部